Do not base your investment decision based on posters posts. There were some very smart and well spoken people on the CVS board saying that CVS was going to crash and burn when they bought Caremark. they had the most di hard defenders of CVS questioning their investments. FYI CVS cash down from $40 to $23. This week CVS hit $90.
Follow your own convictions
I have just started reading this board but if we are on the topic of the poster
trader537 It's post like this that gives me pause. Some people don't need to be so 'transparent' to be taken seriously
trader537 • Nov 18, 2014 11:57 AM Flag
Twice now, I am in for a truck load of money. This POS better get above $16 some time soon. If I have to I'll take a write off against my profits this year. I am up quite a bit this year, so I'll cut my tax liability as a worst case scenario.
He still owes the bank over $11 a share on his recent $77 short ..How many years of tax write-offs do you think he has from shorting CVS ?
It's means nothing if they don't do a major adverting blitz...I live in New England I don't see any Ads on TV or hear any on the radio ..They have to spend money to make money
Gold slides as Swiss support for referendum wanes
By Sue Chang and Victor Reklaitis
Published: Nov 19, 2014 2:29 p.m. ET
Gold bars and a Swiss Franc coin are seen in this illustration picture taken at an Austrian plant. REUTERS/Leonhard Foeger
SAN FRANCISCO (MarketWatch)—Gold retreated on reports Wednesday that support for a Swiss referendum to require the country’s central bank to hold 20% of its reserves in gold bullions is losing momentum.
Only about 38% of those polled plan to vote for the Swiss gold measure, according to the Daily Mail, while Bloomberg reported that about 47% are likely to vote against it. The referendum, scheduled for Nov. 30, must secure more than 50% support to pass.
CVS had its price target increased by Argus from $85.00 to $95.00 in a research report sent to investors last Wednesday morning. The firm currently has a buy rating on the stock.
Analysts at Mizuho lifted their price target on shares of CVS Health Corp ) from $85.00 to $103.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. Mizuho’s target price suggests a potential upside of 14.75% from the company’s current price.